Vystar® Corporation Partners with Specialized Sleep Diagnostics LLC and SleepRx, Inc. to Provide Durable Medical Equipment (DME) to SleepHealth™ Customers

Vystar^® Corporation (VYST), the exclusive creator of Vytex^® Natural Rubber Latex (NRL), a multi-patented, all-natural raw material that contains significantly reduced levels of non-rubber particles and proteins found in natural rubber latex, announced that it has entered into two significant relationships with durable medical equipment (DME) providers: Specialized Sleep Diagnostics LLC and SleepRx, Inc. for the southeastern U.S. region.  With these new business relationships, Vystar's SleepHealth™ division will now offer a full range of sleep-related equipment and supplies to patients in the convenience of their sleep center.  According to industry estimates the U.S. Sleep market segment for CPAP Sleep Apnea devices is over $1.5 billion.

Patients of SleepHealth's physician customers in Georgia and South Carolina will now be able to be trained on the use of their prescribed CPAP (Continuous Positive Airway Pressure)equipment, receive other needed DME, and sleep-related supplies directly through SleepHealth's services.

Specialized Sleep Diagnostics is led by Francis B. Buda, MD, FAAP, ABPN(C), ABSM, who has been actively involved in the field of sleep medicine for over 30 years. He also currently holds the position as director for the Atlanta Center for Sleep Disorders at Atlanta Medical Center and is also Medical Director for Real Results Weight Loss Solutions. Dr. Buda's board certifications include the American Board of Pediatrics, American Board of Neurology and Psychiatry, and American Board of Sleep Medicine.  Dr. Buda is also the author of the book, Holistic Sleep: Beating Insomnia with Commonsense, Medical, and New Age Techniques.

Dr. Buda, President of Specialized Sleep Diagnostics, commented, "I am thrilled to be able to continue my working relationship with Ailene Miller, General Manager of the SleepHealth division of Vystar Corporation.  Through our joint efforts we will be a valued asset to the physicians' offices that maintain a SleepHealth sleep clinic.  Being able to send a patient home with their prescribed and titrated CPAP equipment saves valuable time by starting their treatments immediately."           

Vystar also entered into an agreement with SleepRx, Inc. which will offer similar DME supplies to patients in a SleepHealth managed clinic located primarily in South Carolina.  SleepRx is a hybrid sleep testing center providing diagnostic studies, CPAP and BiPAP supplies, as well as Home Sleep Testing services. Dawn Ankney, President and Founder of SleepRx, has been in the sleep industry for over 25 years and has developed numerous relationships with national providers of sleep diagnostics and treatment options. Visit www.sleeprx.net for more information.

Ms. Ankney, President of SleepRx, commented, "Our partnership with Vystar's SleepHealth division allows for significant growth throughout a broad base of physicians serving patients who currently need to travel a great distance for sleep testing.  We are targeting areas where patients needing a sleep study can simply go as far as their physician's office to complete their authorized study, and then leave with the prescribed equipment.  We will also use this alliance to test market a storefront concept that will include 100% all natural rubber latex pillows made with Vystar's patented Vytex NRL.  Vystar has assumed responsibility to handle the re-supply of DME to SleepRx's existing large database of patients.  We are excited to tap in to Vystar's marketing and public relations efforts." 

William Doyle, President and CEO of Vystar Corporation, commented, "We have already started to implement these two important relationships and are eager to continue growing this exciting new revenue stream. The strategic alliances with Specialized Sleep Diagnostics and SleepRx will allow our SleepHealth Division to provide needed DME equipment and associated support to patients of our SleepHealth accounts. Fitting, titrating and managing CPAP patients and their supplies is a time consuming process. With these new contracts, SleepHealth can offer our accounts the opportunity to provide their sleep apnea patients with access to prescribed equipment, supplies and support more easily. Our goal is to be the single, intensive sleep health resource, for our physicians' offices on a daily basis. By offering DME services and support, including re-supply and DME compliance monitoring, we further support our physicians' efforts to manage their patients with sleep health conditions."

About Vystar Corporation

Based in Duluth, GA, Vystar^® Corporation (OTC Bulletin Board: VYST) is the exclusive creator of Vytex^® Natural Rubber Latex (Vytex NRL), a multi-patented, all-natural, raw material that contains significantly reduced levels of the proteins found in natural rubber latex and can be used in over 40,000 products. Vytex NRL is a 100% renewable resource, environmentally safe, "green" and fully biodegradable. Vystar is working with manufacturers across a broad range of consumer and medical products to bring Vytex NRL to market in adhesives, balloons, surgical and exam gloves, other medical devices and natural rubber latex foam mattresses and pillows. Vystar's SleepHealth acquisition provides an entry into the health and wellness market. For more information, visit www.vytex.com.

Forward-looking Statements: Investors are cautioned that certain statements contained in this document as well as some statements in periodic press releases and some oral statements of VYST officials are "Forward-Looking Statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions, which include words such as "believes," "anticipates," "intends," "plans," "expects," and similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible future VYST actions, which may be provided by management, are also forward-looking statements as defined by the Act. Forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements and to vary significantly from reporting period to reporting period. Although management believes that the assumptions made and expectations reflected in the forward-looking statements are reasonable, there is no assurance that the underlying assumptions will, in fact, prove to be correct or that actual future results will not be different from the expectations expressed in this report. These statements are not guarantees of future performance and VYST has no specific intention to update these statements.